Naphthalenesulfonamides as calmodulin antagonists.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002845:Chromatography; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009219:Myosin-Light-Chain Kinase; D009282:Naphthalenesulfonates / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D047428:Protein Kinase Inhibitors; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000494:pharmacology*
D002147:Calmodulin; D009282:Naphthalenesulfonates; D010640:Phenothiazines; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; C017967:W 7; D009219:Myosin-Light-Chain Kinase; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases